Please use this identifier to cite or link to this item:
https://doi.org/10.1056/nejmc2036175
| Title: | Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes | Authors: | George L. Bakris Rajiv Agarwal Stefan D. Anker Bertram Pitt Luis M. Ruilope Peter Rossing Peter Kolkhof Christina Nowack Patrick Schloemer Amer Joseph Gerasimos Filippatos for the FIDELIO-DKD Investigators |
Issue Date: | 18-Mar-2021 | Publisher: | Massachusetts Medical Society | Citation: | George L. Bakris, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph, Gerasimos Filippatos, for the FIDELIO-DKD Investigators (2021-03-18). Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. New England Journal of Medicine 384 (11) : e42-e42. ScholarBank@NUS Repository. https://doi.org/10.1056/nejmc2036175 | Source Title: | New England Journal of Medicine | URI: | https://scholarbank.nus.edu.sg/handle/10635/229778 | ISSN: | 00284793 15334406 |
DOI: | 10.1056/nejmc2036175 |
| Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Effect of Finerenone on Chronic Kidney -NEJM.pdf | 751.7 kB | Adobe PDF | OPEN | Published | View/Download | |
| Effect of Finerenone on Chronic Kidney -NEJM-appendix.pdf | 930.84 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.